CAT# | CPM-1-0284 |
Sequence | LFGYPVYVF |
Size | 50 Test, 100 Test | Antigen | Virus | Epitope Origin | HTLV-1 Tax12-20 | MHC Restriction | HLA-A_24_02 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0570 | HLA-A_02_01 BTG1 tetramer-TLWVDPYEV-PE labeled | Inquiry | ||
CPM-1-0347 | HLA-B_07_02 HIV gag tetramer-GPGHKARVL-BV421 labeled | Inquiry | ||
CPM-1-0204 | HLA-A_24_02 ACC-1 tetramer-DYLQYVLQI-PE labeled | Inquiry | ||
CPM-1-0798 | HLA-A_02_01 Sur9 tetramer-ELTLGEFLKL-PE labeled | Inquiry | ||
CPM-1-0562 | HLA-A_02_01 HBV env 335-343 tetramer-WLSLLVPFV-APC labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PKC (19-36), a synthetic peptide of the pseudosubstrate domain of the kinase, is a selective inhibitor of prote ...
UFP-803 (H-Asp-c[Pen-Phe-DTrp-Dab-Tyr-Cys]-Val-OH), [Pen 5, DTrp 7, Dab 8] U-II (4-11), is a peptidic UT (urote ...
An overview of Tripeptide-10 Citrulline Signal oligopeptides are commonly synthesized from portions of EMPs and from natural ...
5. Synthetic Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced InflammationSynthetic amphipathic helical peptides ...
Guangxitoxin 1E is a KV2.1 and KV2.2 specific channel blocker (IC50 values are 1-3 nM). The experimental results ...